
TerrAscend Corp. (CSE: TER) (OTCQX: TRSSF) will help bring Berner’s Cookies products to Pennsylvania.
TerrAscend said that it has entered into a multi-year agreement with TRP — the cannabis holding and operating company with the exclusive rights Cookies products — to cultivate and manufacture Cookies products in the Keystone State.
“Pennsylvania has always shown Cookie’s love and we could not be more excited to expand our reach on the East Coast with our partner TerrAscend,” said Berner, co-founder and CEO of Cookies. “We’re excited to launch a fresh menu of California flavors, in what has become a very strong and important market for cannabis in the US.”
The company said that it will soon launch Cookies products at each of the company’s ‘Apothecarium’ and ‘Keystone Canna Remedies’ dispensary retail chains in Plymouth- Meeting, Lancaster, Thorndale, Bethlehem, Allentown and Stroudsburg.
The trio has already made strides together in the New Jersey market, where the group launched “Cookies Corner” — a portion of the store dedicated to Cookies products — at a TerrAscend ‘Apothecarium’ dispensary.
Last week we celebrated the opening of Cookies Corner in The Apothecarium NJ. Thank you to everyone who came out and a big thank you to the King of Cannabis, @Berner415! #TerrAscend #cannabis #cannabisindustry #cookiescorner $TER $TRSSF pic.twitter.com/DNRqVM70J0
— TerrAscend (@terrascendcorp) August 23, 2022
“TRP is excited to partner with TerrAscend to bring some of the most desirable genetics out there to the patients of the Pennsylvania, and are looking forward to providing patients with the full Cookies experience when we open our flagship stores in the commonwealth” said TRP co-founder and CEO Brandon Johnson.
Strains from Cookies premium genetics will be made available at TerrAscend dispensaries, as well as Cookies stores owned and operated by TRP that are slated to open in the coming months.
“It’s exciting to announce this agreement and continue to collaborate with Berner and his team on sharing these world-class products with patients in Pennsylvania“, said Jason Wild, executive chairman of TerrAscend.